AC Immune SA (ACIU)
2.40
+0.01
(+0.42%)
USD |
NASDAQ |
Oct 19, 14:46
AC Immune Cash from Operations (Annual) : -83.40M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -83.40M |
| December 31, 2024 | 74.76M |
| December 31, 2023 | -67.22M |
| December 31, 2022 | -77.03M |
| December 31, 2021 | -71.85M |
| December 31, 2020 | -63.41M |
| Date | Value |
|---|---|
| December 31, 2019 | 55.57M |
| December 31, 2018 | -45.04M |
| December 31, 2017 | -22.45M |
| December 31, 2016 | -5.731M |
| December 31, 2015 | 45.78M |
| December 31, 2014 | -19.25M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Precigen, Inc. | -87.83M |
| Basilea Pharmaceutica AG | 74.76M |
| Santhera Pharmaceuticals Holding AG | -41.86M |
| Aldeyra Therapeutics, Inc. | -33.35M |
| BeOne Medicines Ltd. | 1.131B |